Intracranial delivery of IL-13Rα2-directed CAR-T cells into the resection cavity of three patients with recurrent GBM led to a transient anti-tumor response in two patients, as indicated by an increased MRI gadolinium enhancement and increased FLAIR signal [57]. The gene discussed is IL13RA2; the disease is neoplasm.